TG Therapeutics, Inc.
TGTX NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 3, 2026
ET
EPS Est.
0.31
EPS Actual
0.05
Revenue Est.
$229.8M
Revenue Actual
$240.3M
Next Earnings Report
Date
Nov 2, 2026 · Mon
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
0.36
Revenue Est.
$247.1M
Company Overview
TG Therapeutics, Inc. (ticker TGTX) is listed on NASDAQ with a market cap of about $8.31B. Its next earnings report (FY2026 Q3) is expected on Nov 2, 2026 (ET), Pre-market, with consensus EPS of 0.36. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Feb 28, 2023 → Aug 3, 2026
Feb 28, 2023Range: -0.39 ~ 2.43Aug 3, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 3, 2026 | -- | 0.31 | Below forecast↓0.05 | $229.8M | $240.3M |
| May 6, 2026 | -- | 0.23 | Below forecast↓0.14 | $200.3M | $204.9M |
| Feb 26, 2026 | -- | 0.35 | Below forecast↓0.14 | $191.8M | $192.6M |
| Nov 3, 2025 | -- | 0.24 | Above forecast↑2.43 | $193.8M | $161.7M |
| Aug 4, 2025 | -- | 0.32 | Below forecast↓0.17 | $146.3M | $141.1M |
| May 5, 2025 | -- | 0.18 | Below forecast↓0.03 | $134.2M | $120.9M |
| Mar 3, 2025 | -- | 0.08 | Above forecast↑0.15 | $108.8M | $108.2M |
| Nov 4, 2024 | -- | 0.03 | Below forecast↓0.02 | $98.8M | $83.9M |
| Aug 6, 2024 | -- | -0.05 | Above forecast↑0.04 | $65.9M | $73.5M |
| May 1, 2024 | -- | -0.04 | Below forecast↓-0.07 | $54.6M | $63.5M |
| Feb 28, 2024 | -- | -0.12 | Above forecast↑-0.09 | $40.1M | $44M |
| Nov 1, 2023 | -- | 0.12 | Above forecast↑0.73 | $38.7M | $165.8M |
| Aug 1, 2023 | -- | -0.26 | Below forecast↓-0.34 | $47.1M | $16.1M |
| May 1, 2023 | -- | -0.36 | Above forecast↑-0.28 | $14.4M | $7.8M |
| Feb 28, 2023 | -- | -0.26 | Below forecast↓-0.39 | $1.6M | $80000 |
Original Filings (SEC)
10-Q2026-08-05 ↗
8-K2026-08-03 ↗
8-K2026-06-12 ↗
8-K2026-06-03 ↗
8-K2026-05-27 ↗
10-Q2026-05-06 ↗
8-K2026-05-06 ↗
8-K2026-03-20 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
